tirzepatide class of drug vs. Semaglutide: What You Should Know What Kind of Drug is

Ozempic Prescribed under the brand names Ozempic and Wegovy, semaglutide (the generic name) is a glucagon-like peptide-1 (GLP-1) agonist medication

Demographic information, such as age, sex, race and ethnicity, were self-reported by eligible participants

Your clinician knows your name, your history, and your goals, and every interaction is designed to support your success

The acclimation period matters

Who is eligible for tirzepatide

Semaglutide vs Tirzepatide: The Core Differences Comparison point Semaglutide Tirzepatide Hormone pathway GLP-1 receptor agonist Dual GIP and GLP-1 receptor agonist Weight-management brand Wegovy Zepbound Diabetes brand with the same active ingredient Ozempic Mounjaro Current weight-management forms Injection and tablet Injection Direct 72-week obesity trial 13.7% mean weight reduction 20.2% mean weight reduction Notable FDA-labeled consideration Major cardiovascular event risk reduction in certain adults with established cardiovascular disease and overweight or obesity Moderate to severe obstructive sleep apnea in adults with obesity Main tolerability concern Gastrointestinal symptoms Gastrointestinal symptoms SURMOUNT-5 was a randomized phase 3b trial of adults with obesity without diabetes treated with maximum tolerated doses for 72 weeks